Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Clinical trial NCT00266669 · COMPLETED

Trial details

NCT number: NCT00266669
Sponsor: MediQuest Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Raynaud's Disease

Start date: 2005-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.